[go: up one dir, main page]

ES2061621T3 - Nuevas lactamas triciclicas que contienen sulfhidrilo y sus metodos farmacologicos de uso. - Google Patents

Nuevas lactamas triciclicas que contienen sulfhidrilo y sus metodos farmacologicos de uso.

Info

Publication number
ES2061621T3
ES2061621T3 ES88121850T ES88121850T ES2061621T3 ES 2061621 T3 ES2061621 T3 ES 2061621T3 ES 88121850 T ES88121850 T ES 88121850T ES 88121850 T ES88121850 T ES 88121850T ES 2061621 T3 ES2061621 T3 ES 2061621T3
Authority
ES
Spain
Prior art keywords
sulfhidrile
pharmacological methods
tricyclic lactams
lactams containing
new tricyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88121850T
Other languages
English (en)
Inventor
Gary A Flynn
Douglas W Beight
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2061621T3 publication Critical patent/ES2061621T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

ESTA INVENCION SE REFIERE A LACTAMA TRICICLICA CONTENIENDO S DE DONFORMACION RIGIDA, A LOS INTERMEDIARIOS Y PROCESOS UTILES PARA SU PREPARACIOM Y A SUS EFECTOS FARMACOLOGICOS EN LA INHIBICION DE ENZIMA CONVERTIDORA DE ANGIOTENSINA, AL TRATAR EL DAÑO POR REPERFUSION Y AL TRATAR ALTERACIONES CARDIACAS
ES88121850T 1987-12-30 1988-12-29 Nuevas lactamas triciclicas que contienen sulfhidrilo y sus metodos farmacologicos de uso. Expired - Lifetime ES2061621T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/139,485 US4824832A (en) 1987-12-30 1987-12-30 Sulfhydryl containing tricyclic lactams and their pharmacological methods of use

Publications (1)

Publication Number Publication Date
ES2061621T3 true ES2061621T3 (es) 1994-12-16

Family

ID=22486887

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88121850T Expired - Lifetime ES2061621T3 (es) 1987-12-30 1988-12-29 Nuevas lactamas triciclicas que contienen sulfhidrilo y sus metodos farmacologicos de uso.

Country Status (18)

Country Link
US (1) US4824832A (es)
EP (1) EP0322914B1 (es)
JP (1) JP2681291B2 (es)
KR (1) KR0128158B1 (es)
CN (1) CN1034721A (es)
AT (1) ATE100453T1 (es)
AU (1) AU611984B2 (es)
CA (1) CA1336191C (es)
DE (1) DE3887307T2 (es)
DK (1) DK725988A (es)
ES (1) ES2061621T3 (es)
FI (1) FI886005A (es)
HU (2) HU204050B (es)
IL (1) IL88810A (es)
NO (1) NO885812L (es)
NZ (1) NZ227432A (es)
PT (1) PT89346B (es)
ZA (1) ZA889542B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5208230A (en) * 1990-12-21 1993-05-04 Merrell Dow Pharmaceuticals Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
CA2057786C (en) * 1990-12-21 2002-06-18 Gary A. Flynn Amino and nitro containing tricyclic compounds useful as inhibitors or ace
US5308841A (en) * 1990-12-21 1994-05-03 Merrell Dow Pharmaceuticals Inc. Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
ES2106112T3 (es) * 1991-09-27 1997-11-01 Merrell Pharma Inc Derivados de indano-2-mercaptoacetilamida con una actividad inhibidora de encefalinasa y de ace.
CA2078759C (en) * 1991-09-27 2003-09-16 Alan M. Warshawsky Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
US5457196A (en) * 1991-09-27 1995-10-10 Merrell Dow Pharmaceuticals Inc. 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
US5455242A (en) * 1991-09-27 1995-10-03 Merrell Dow Pharmaceuticals Inc. Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
DE69317764T2 (de) * 1992-02-14 1998-07-30 Merrell Pharmaceuticals Inc., Cincinnati, Ohio Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
HU223663B1 (hu) * 1992-05-15 2004-11-29 Merrel Dow Pharmaceuticals Inc. Enkefalináz és ACE gátló hatású 9-[(2-acetil-tio-3-fenil)-propanoil-amino]-piridazo[1,2-a][1,2]diazepin-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
US5420271A (en) * 1992-08-24 1995-05-30 Merrell Dow Pharmaceuticals, Inc. 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
DE69329701T2 (de) * 1992-10-30 2001-05-10 Merrell Pharmaceuticals Inc., Cincinnati Mercaptoacetylamid substituiertes bizyclisches laktam zur verwendung als enkephalinase und ace-hemmer
US5654294A (en) * 1993-05-13 1997-08-05 Bristol-Myers Squibb Spiro lactam dual action inhibitors
US5362727A (en) * 1993-07-26 1994-11-08 Bristol-Myers Squibb Substituted azepino[2,1-a]isoquinoline compounds
US5525723A (en) * 1993-11-18 1996-06-11 Bristol-Myers Squibb Co. Compounds containing a fused multiple ring lactam
DE69407430T2 (de) * 1993-11-19 1998-04-09 Merrell Pharmaceuticals Inc., Cincinnati, Ohio Neues verfahren zur herstellung von (s)-1-[2(s)-(1,3-dihydro-1,3-dioxoisoindol-2-yl)-1-oxo-3-phenylpropyl]-1,2,3,4-tetrahydropyridin-2-carbonsäuremethylester und dessen zwischenprodukte
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
NZ279397A (en) * 1994-02-14 1997-08-22 Merrell Pharma Inc Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives and pharmaceutucal compositions
ES2168355T3 (es) * 1994-02-14 2002-06-16 Merrell Pharma Inc Derivados de bisulfuro de indano-2-mercaptoacetilamida utiles como inhibidores de la encefalinasa.
KR100357354B1 (ko) * 1994-02-14 2003-01-30 메렐 파마슈티칼스 인크. 엔케팔리나제및안지오텐신전환효소(ace)의억제제로서유용한신규의머캅토아세틸아미드디설파이드유도체
HUT76479A (en) * 1994-02-14 1997-09-29 Merrell Pharma Inc Novel fused benzazepinone derivatives, process for preparation thereof and pharmaceutical composition containing them
US5484783A (en) * 1994-03-24 1996-01-16 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
HUT75160A (en) * 1994-03-24 1997-04-28 Merrell Pharma Inc Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives
AU688012B2 (en) * 1994-03-24 1998-03-05 Merrell Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives
PT957109E (pt) * 1994-12-21 2004-09-30 Aventis Pharma Inc Novos processos para a preparacao de intermediarios de inibidores da enzima conversora da encefalinase e da angiotensina e seus intermediarios
US5641880A (en) * 1994-12-21 1997-06-24 Hoechst Marion Roussel, Inc. Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors
GB0119305D0 (en) 2001-04-12 2001-10-03 Aventis Pharma Gmbh Mercaptoacetylamide derivatives,a process for their preparation and their use
US20030229007A1 (en) * 2002-05-30 2003-12-11 Roberto Levi Form of human renin and its use as a target in treatments for cardiac ischemia and arrhythmia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3185680A (en) * 1962-10-16 1965-05-25 American Home Prod Reduced benzodiazepinium compounds
US4584294A (en) * 1984-11-07 1986-04-22 Merck & Co., Inc. Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
CA1337654C (en) * 1986-06-13 1995-11-28 Gary A. Flynn Fused tricyclic lactams as antihypertensive agents

Also Published As

Publication number Publication date
US4824832A (en) 1989-04-25
PT89346A (pt) 1989-12-29
AU611984B2 (en) 1991-06-27
HU200181B (en) 1990-04-28
DE3887307D1 (de) 1994-03-03
NO885812L (no) 1989-07-03
HU895880D0 (en) 1990-02-28
HU204050B (en) 1991-11-28
AU2736888A (en) 1989-07-06
NO885812D0 (no) 1988-12-29
CA1336191C (en) 1995-07-04
IL88810A0 (en) 1989-07-31
ATE100453T1 (de) 1994-02-15
EP0322914B1 (en) 1994-01-19
KR890009927A (ko) 1989-08-04
CN1034721A (zh) 1989-08-16
DE3887307T2 (de) 1994-05-05
JP2681291B2 (ja) 1997-11-26
EP0322914A3 (en) 1990-12-27
DK725988D0 (da) 1988-12-28
ZA889542B (en) 1989-09-27
DK725988A (da) 1989-07-01
FI886005A (fi) 1989-07-01
EP0322914A2 (en) 1989-07-05
KR0128158B1 (ko) 1998-04-04
IL88810A (en) 1993-08-18
JPH01203382A (ja) 1989-08-16
HUT49137A (en) 1989-08-28
PT89346B (pt) 1993-08-31
NZ227432A (en) 1990-11-27

Similar Documents

Publication Publication Date Title
ES2061621T3 (es) Nuevas lactamas triciclicas que contienen sulfhidrilo y sus metodos farmacologicos de uso.
NZ212750A (en) 3-acylamino-2-azetidinone derivatives useful as intermediates in the preparation of antibacterial agents
TNSN87033A1 (fr) TOLUNITRILES SUBSTITUES PAR DESα - HETEROCYCLES
EP0435321A3 (en) Novel a-nor-steroid-3-carboxylic acid derivatives
ES2159714T3 (es) Hidroximetil-imidazodiazepinas y sus esteres.
ES8604128A1 (es) Un procedimiento para la preparacion de nuevos derivados de bencenosulfonamida
FI943313A0 (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
IE872588L (en) Compounds
EP0270267A3 (en) Anxiolytic composition
MX170732B (es) Composicion de derivados de succinimida y su uso
ATE73821T1 (de) Pyrrolidonderivate.
DE3567210D1 (en) Isoindolinone derivatives, production and use thereof
DE3664634D1 (en) Substituted o-sulfonyl-glycosyl amides, method for their preparation and their use as mediacments
DK56687D0 (da) 5-substitueret octahydroindolizinforbindelser samt 7-ketomellemprodukter ved fremstillingen heraf
HUP9901975A2 (hu) Bisz(indolil)-maleinmid-csoportot tartalmazó makrociklusos vegyületek és alkalmazásuk intermedierként
DK7286A (da) Octahydroindoliziner
FR2445838A1 (fr) Nouveaux 1a,3b-dihydroxy-5-steroides
EP0574271A3 (es)
FR2361335A1 (fr) 4-(3-(amino substitue)-2-hydroxypropoxy) - 5,6,7,8 - tetrahydro - 1,6,7 - naphtalenetriol
ES8704852A1 (es) Procedimiento para depurar azufre liquido
DE3669508D1 (de) Verbrueckungsreagenz, verfahren zu seiner herstellung und seine anwendung.
FR2396011A1 (fr) Nouvelles 2,3-dihydro-1,4-benzoxathines pour inhibition de lipogenese

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 322914

Country of ref document: ES